MicrosoftTeams-image (5).png
USD 12.6 Bn Cancer Biomarkers Market to Grow at a CAGR of 9.9% During 2022 to 2031 - Global Analysis by Transparency Market Research
26 avr. 2023 06h30 HE | Transparency Market Research
Wilmington, Delaware, United States, April 26, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, tThe global cancer biomarkers market size stood at USD 12.6 Bn in 2021. The market...
retinai_logo_RGB_black (1).png
RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence
21 avr. 2023 03h00 HE | RetinAI Medical AG
BERN, Switzerland and BOSTON, April 21, 2023 (GLOBE NEWSWIRE) -- RetinAI Medical AG (“RetinAI”), a leader in clinical and imaging data management software and advanced analytics using artificial...
MicrosoftTeams-image (5).png
Congestive Heart Failure Drugs Market Size to Cross USD 13.5 Bn Revenue by 2031 | TMR Study
13 avr. 2023 17h30 HE | Transparency Market Research
Wilmington, Delaware, United States, April 14, 2023 (GLOBE NEWSWIRE) -- The global congestive heart failure drugs market was valued at USD 6.7 Bn in 2022 and is estimated to reach USD 13.5 Bn by...
logo.png
Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up
11 avr. 2023 05h00 HE | Paradigm Biopharmaceuticals
MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Australia’s Paradigm Biopharmaceuticals Ltd (ASX:PAR) says analysis of six-month trial data shows injectable pentosan polysulfate sodium...
MicrosoftTeams-image (5).png
Radiopharmaceutical Theranostics Market Size to Cross USD 12.4 Bn by 2031 | Transparency Market Research
03 avr. 2023 17h30 HE | Transparency Market Research
Wilmington, Delaware, United States, April 04, 2023 (GLOBE NEWSWIRE) -- The global radiopharmaceutical theranostics market was valued at USD 3.0 Bn in 2022 and is projected to reach USD 12.4 Bn by...
MnM_logo_TM_JPG.JPG
Biomarkers Market is Expected to Reach $104.0 billion | MarketsandMarkets.
31 mars 2023 09h30 HE | MarketsandMarkets Research Pvt. Ltd.
Chicago, March 31, 2023 (GLOBE NEWSWIRE) -- The future of biomarkers is expected to be a very promising one. As new technologies and techniques continue to emerge, the use of biomarkers will become...
Biomarkers Market Size to Surpass USD 97.51 Billion by 2026 | With 12.1% CAGR
06 févr. 2023 07h44 HE | Fortune Business Insights
Pune, India, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The global Biomarkers Market size stood at USD 39.10 billion in 2018. The market is slated to expand USD 97.51 billion by 2026, exhibiting a CAGR of...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
08 déc. 2022 16h10 HE | Inotiv, Inc.
WEST LAFAYETTE, Ind., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
TIP_link_300x300.jpg
With 13% of CAGR, Neurological Biomarker Market to Gain $14+ Billion Revenue by 2027 | Exclusive Report by The Insight Partners
14 nov. 2022 06h58 HE | The Insight Partners
New York, Nov. 14, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on "Neurological Biomarker Market Size, Share, Growth, Trends and Forecast to 2027 – COVID-19 Impact and...
Vantage Market Research.png
Cancer Biomarkers Market Size & Share to Surpass $31.8 Bn by 2028 | Vantage Market Research
10 nov. 2022 11h49 HE | Vantage Market Research
WASHINGTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The global Cancer Biomarkers Market was valued at $12.1 Billion in 2021 and is expected to reach $31.8 Billion by 2028, registering a CAGR of 17.5%...